Supramolecular Coordination Complexes As Diagnostic and Therapeutic Agents

Overview

Journal Curr Opin Chem Biol

Publisher Elsevier

Specialty Biochemistry

Date 2020 Nov 4

PMID 33147551

Citations 7

Authors

Guocan Yu

Meijuan Jiang

Feihe Huang

Xiaoyuan Chen

Affiliations

Soon will be listed here.

Abstract

The metal-based drugs represented by cisplatin, carboplatin, and oxaliplatin, prevail in cancer treatment, whereas new therapeutics are extremely slow to step into the clinic. Poor pharmacokinetics, multidrug resistance, and severe side effects greatly limit the development of metal-based anticancer drugs. The robustness and modular composition of supramolecular coordination complexes allow for the incorporation of novel diagnostic and therapeutic modalities, showing promising potentials for precise cancer theranostics. In this mini review, we highlight the recent advances in the development of supramolecular coordination complexes as diagnostic and therapeutic agents. The key focuses of these reports lie in searching sophisticated coordination ligands and nanoformulations that can potentially solve the issues faced by current metal-based drugs including imaging, resistance, toxicity, and pharmacological deficiencies.

Citing Articles

In Silico Insights Reveal Fibronectin 1 as a Theranostic Marker in Gastric Cancer.

Millapan T, Gutierrez A, Rosas K, Buchegger K, Ili C, Brebi P Int J Mol Sci. 2024; 25(20).

PMID: 39456895 PMC: 11507984. DOI: 10.3390/ijms252011113.

Multilevel Hollow-Structured Particles through Halogen-Bond Regulated Polymer Assembly under 3D Confinement.

Zheng X, Zhao Y, Zhang Y, Deng R, Li B, Chen S Adv Sci (Weinh). 2024; 11(41):e2405103.

PMID: 39229787 PMC: 11538654. DOI: 10.1002/advs.202405103.

Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer.

Santos M, de Azevedo Teotonio Cavalcanti M, de Medeiros E Silva Y, Nascimento I, Olimpio de Moura R Anticancer Agents Med Chem. 2023; 24(4):236-262.

PMID: 38038012 DOI: 10.2174/0118715206269722231121173311.

Rhenium-Pyrazolyl-Based Figure-Eight- and Z-Shaped Metallocycles: Self-Assembly, Solid-State Structures, Dynamic Properties in Solution, and Competitive Ligand-Induced Supramolecular Transformations into....

Phukon U, Kedia M, Shankar B, Sathiyendiran M ACS Omega. 2023; 8(44):41773-41784.

PMID: 37969972 PMC: 10633831. DOI: 10.1021/acsomega.3c06371.

Rationally designed Ru(ii)-metallacycle chemo-phototheranostic that emits beyond 1000 nm.

Li C, Xu Y, Tu L, Choi M, Fan Y, Chen X Chem Sci. 2022; 13(22):6541-6549.

PMID: 35756528 PMC: 9172562. DOI: 10.1039/d2sc01518h.

References

Yu G, Chen X . Host-Guest Chemistry in Supramolecular Theranostics. Theranostics. 2019; 9(11):3041-3074. PMC: 6567976. DOI: 10.7150/thno.31653. View

Davoodi P, Lee L, Xu Q, Sunil V, Sun Y, Soh S . Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev. 2018; 132:104-138. DOI: 10.1016/j.addr.2018.07.002. View

Sepehrpour H, Fu W, Sun Y, Stang P . Biomedically Relevant Self-Assembled Metallacycles and Metallacages. J Am Chem Soc. 2019; 141(36):14005-14020. PMC: 6744948. DOI: 10.1021/jacs.9b06222. View

Qin Y, Chen L, Dong F, Jiang S, Yin G, Li X . Light-Controlled Generation of Singlet Oxygen within a Discrete Dual-Stage Metallacycle for Cancer Therapy. J Am Chem Soc. 2019; 141(22):8943-8950. DOI: 10.1021/jacs.9b02726. View

Vajpayee V, Song Y, Yang Y, Kang S, Cook T, Kim D . Self-assembly of Cationic, Hetero- or Homo-nuclear Ru(II) Macrocyclic Rectangles and their Photophysical, Electrochemical and Biological Studies. Organometallics. 2011; 30(23):6482-6489. PMC: 3238491. DOI: 10.1021/om200908c. View

Vajpayee V, Yang Y, Kang S, Kim H, Kim I, Wang M . Hexanuclear self-assembled arene-ruthenium nano-prismatic cages: potential anticancer agents. Chem Commun (Camb). 2011; 47(18):5184-6. PMC: 3441832. DOI: 10.1039/c1cc10167f. View

Zhou Z, Liu J, Huang J, Rees T, Wang Y, Wang H . A self-assembled Ru-Pt metallacage as a lysosome-targeting photosensitizer for 2-photon photodynamic therapy. Proc Natl Acad Sci U S A. 2019; 116(41):20296-20302. PMC: 6789806. DOI: 10.1073/pnas.1912549116. View

Zheng Y, Suntharalingam K, Johnstone T, Lippard S . Encapsulation of Pt(IV) Prodrugs within a Pt(II) Cage for Drug Delivery. Chem Sci. 2015; 6(2):1189-1193. PMC: 4303084. DOI: 10.1039/C4SC01892C. View

Sun Y, Ding F, Chen Z, Zhang R, Li C, Xu Y . Melanin-dot-mediated delivery of metallacycle for NIR-II/photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy. Proc Natl Acad Sci U S A. 2019; 116(34):16729-16735. PMC: 6708342. DOI: 10.1073/pnas.1908761116. View

10.

Yu G, Zhang M, Saha M, Mao Z, Chen J, Yao Y . Antitumor Activity of a Unique Polymer That Incorporates a Fluorescent Self-Assembled Metallacycle. J Am Chem Soc. 2017; 139(44):15940-15949. PMC: 5827967. DOI: 10.1021/jacs.7b09224. View

11.

Northrop B, Yang H, Stang P . Coordination-driven self-assembly of functionalized supramolecular metallacycles. Chem Commun (Camb). 2008; (45):5896-908. PMC: 2621066. DOI: 10.1039/b811712h. View

12.

Li B, He T, Fan Y, Yuan X, Qiu H, Yin S . Recent developments in the construction of metallacycle/metallacage-cored supramolecular polymers via hierarchical self-assembly. Chem Commun (Camb). 2019; 55(56):8036-8059. DOI: 10.1039/c9cc02472g. View

13.

Jo S, Ku S, Won Y, Kim S, Kwon I . Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy. Theranostics. 2016; 6(9):1362-77. PMC: 4924505. DOI: 10.7150/thno.15335. View

14.

Yu G, Yang Z, Fu X, Yung B, Yang J, Mao Z . Polyrotaxane-based supramolecular theranostics. Nat Commun. 2018; 9(1):766. PMC: 5823937. DOI: 10.1038/s41467-018-03119-w. View

15.

Kojima R, Aubel D, Fussenegger M . Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells. Curr Opin Chem Biol. 2015; 28:29-38. DOI: 10.1016/j.cbpa.2015.05.021. View

16.

Mishra A, Jeong Y, Jo J, Kang S, Lah M, Chi K . Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls. Chembiochem. 2014; 15(5):695-700. DOI: 10.1002/cbic.201300688. View

17.

Zhou J, Yu G, Huang F . Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future. Chem Soc Rev. 2017; 46(22):7021-7053. DOI: 10.1039/c6cs00898d. View

18.

Ding F, Chen Z, Kim W, Sharma A, Li C, Ouyang Q . A nano-cocktail of an NIR-II emissive fluorophore and organoplatinum(ii) metallacycle for efficient cancer imaging and therapy. Chem Sci. 2019; 10(29):7023-7028. PMC: 6676325. DOI: 10.1039/c9sc02466b. View

19.

Sun Y, Ding F, Zhou Z, Li C, Pu M, Xu Y . Rhomboidal Pt(II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy. Proc Natl Acad Sci U S A. 2019; 116(6):1968-1973. PMC: 6369813. DOI: 10.1073/pnas.1817021116. View

20.

Yu G, Yu S, Saha M, Zhou J, Cook T, Yung B . A discrete organoplatinum(II) metallacage as a multimodality theranostic platform for cancer photochemotherapy. Nat Commun. 2018; 9(1):4335. PMC: 6194061. DOI: 10.1038/s41467-018-06574-7. View